With 60% Ownership of the Shares, Gossamer Bio, Inc. (NASDAQ:GOSS) Is Heavily Dominated by Institutional Owners

Yahoo FinanceMar 3 05:04 ET

Is Gossamer Bio (NASDAQ:GOSS) Weighed On By Its Debt Load?

Simply Wall StFeb 6 05:01 ET

Gossamer Bio Presented Clinical and Preclinical Data at the Pulmonary Vascular Research Institute 2025 Annual Congress

BusinesswireFeb 3 07:01 ET

Gossamer Bio And 2 Other Promising Penny Stocks On US Exchanges

Yahoo FinanceJan 30 08:08 ET

Gossamer Bio's Strategic Focus on PAH Unmet Needs and Seralutinib Efficacy Drives Buy Rating

TipRanksJan 27 01:15 ET · Ratings

12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaDec 12, 2024 16:05 ET

After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)

Zacks Nov 14, 2024 08:40 ET

Gossamer Bio (GOSS) Gets a Buy From Oppenheimer

TipRanksNov 12, 2024 07:46 ET · Ratings

Express News | HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target

BenzingaNov 11, 2024 10:10 ET

Gossamer Bio Analyst Ratings

BenzingaNov 11, 2024 10:08 ET · Ratings

Promising Progress and Expansion Potential of Gossamer Bio's Seralutinib Drive Buy Rating

TipRanksNov 11, 2024 06:17 ET · Ratings

Gossamer Bio, Inc. (NASDAQ:GOSS) Just Reported And Analysts Have Been Lifting Their Price Targets

Yahoo FinanceNov 10, 2024 07:03 ET

Gossamer Bio Reports Revenue Growth Amid Strategic Collaborations

TipRanksNov 8, 2024 23:24 ET

Gossamer Bio: Q3 Earnings Snapshot

Yahoo FinanceNov 7, 2024 16:59 ET

Earnings Flash (GOSS) GOSSAMER BIO Reports Q3 Revenue $9.5M

MT NewswiresNov 7, 2024 16:15 ET

Gossamer Bio | 10-Q: Q3 2024 Earnings Report

SECNov 7, 2024 16:04 ET · Announcements

Gossamer Bio | 8-K: Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update

SECNov 7, 2024 16:04 ET

Gossamer Bio 3Q Loss/Shr 14c >GOSS

Dow JonesNov 7, 2024 16:03 ET

Express News | Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update

ReutersNov 7, 2024 16:03 ET

Express News | Gossamer Bio Q3 Operating Expenses USD 43.399 Million

ReutersNov 7, 2024 16:03 ET